In conclusion, this study expands knowledge in this field showing an almost two-fold increase in NTproBNP levels after a very short period of lifestyle intervention in normotensive severe obese patients without cardiac disease, which might have further clinical implications, considering the role of NT-proBNP as risk factor of impaired glucose tolerance. The gene discussed is NPPB; the disease is heart disorder.